Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1991 2
1992 3
1993 4
1994 1
1995 5
1996 1
1997 1
1999 3
2008 1
2013 1
2014 1
2015 3
2016 2
2017 5
2018 3
2019 1
2020 2
2021 2
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Ruëff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Kimball AB, et al. Among authors: schwinn a. Lancet. 2023 Mar 4;401(10378):747-761. doi: 10.1016/S0140-6736(23)00022-3. Epub 2023 Feb 3. Lancet. 2023. PMID: 36746171 Clinical Trial.
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar MLA, Crépy MN, Stingeni L, Serra-Baldrich E, Baranowski K, Korn S, Kurvits M, Plohberger U, Strange Vest N, Schliemann S; trial investigators. Bissonnette R, et al. Lancet. 2024 Aug 3;404(10451):461-473. doi: 10.1016/S0140-6736(24)01027-4. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033766 Clinical Trial.
[White genital piedra].
Schwinn A, Ebert J, Hamm H, Bröcker EB. Schwinn A, et al. Hautarzt. 1996 Aug;47(8):638-41. doi: 10.1007/s001050050482. Hautarzt. 1996. PMID: 8964708 Review. German.
Baseline results of a living systematic review for COVID-19 clinical trial registrations.
Maguire BJ, McLean ARD, Rashan S, Antonio ES, Bagaria J, Bentounsi Z, Brack M, Caldwell F, Carrara VI, Citarella BW, Dahal P, Feteh VF, H B Guérin M, Kennon K, Bilton Lahaut K, Makuka GJ, Ngu R, Obiesie S, Richmond C, Singh-Phulgenda S, Strudwick S, Tyrrell CSB, Schwinn A, King D, Newton PN, Price RN, Merson L, Stepniewska K, Guérin PJ. Maguire BJ, et al. Among authors: schwinn a. Wellcome Open Res. 2020 Jun 2;5:116. doi: 10.12688/wellcomeopenres.15933.1. eCollection 2020. Wellcome Open Res. 2020. PMID: 33154979 Free PMC article.
A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma.
Burg G, Dummer R, Wilhelm M, Nestle F, Ott MM, Feller A, Hefner H, Lanz U, Schwinn A, Wiede J. Burg G, et al. Among authors: schwinn a. N Engl J Med. 1991 Oct 10;325(15):1078-81. doi: 10.1056/NEJM199110103251506. N Engl J Med. 1991. PMID: 1832485 Free article. No abstract available.
Stability and Priority of Symptoms and Symptom Clusters Among Allogeneic HSCT Patients Within a 5-Year Longitudinal Study.
Esser P, Kuba K, Scherwath A, Johansen C, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander AR, Kröger N, Götze H, Mehnert A. Esser P, et al. Among authors: schwinn a. J Pain Symptom Manage. 2017 Oct;54(4):493-500. doi: 10.1016/j.jpainsymman.2017.07.012. Epub 2017 Jul 13. J Pain Symptom Manage. 2017. PMID: 28711754 Free article.
Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
Gollnick H, Kaufmann R, Stough D, Heikkila H, Andriano K, Grinienko A, Jimenez P; Pimecrolimus Cream 1% in (adult) Eczema: Prevention of Progression Multicentre Investigator Study Group. Gollnick H, et al. Br J Dermatol. 2008 May;158(5):1083-93. doi: 10.1111/j.1365-2133.2008.08484.x. Epub 2008 Mar 13. Br J Dermatol. 2008. PMID: 18341665 Clinical Trial.
43 results